logo
Select company
Select metric
0.67Debt to Equity Ratio
VS
Market
69
Sector
45
Industry
35
History
100
$ 3.07Close
$ 1.6 - $ 3.99 52-Week Range
Ticker Information

Ticker

NRXS

Company Name

NEURAXIS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

NEURAXIS INC - Debt to Equity Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NRXS - D/E Historical data
DateDebt to Equity RatioShareholders EquityTotal Liabilities
6/30/20250.67$ 4.25M$ 2.83M
3/31/202510.72$ 258.48K$ 2.77M
12/31/20241.3$ 2.07M$ 2.69M
9/30/20240$ -1.79M$ 2.94M
6/30/20240$ -5.26M$ 7.89M
3/31/20240$ -3.18M$ 4.13M
12/31/20230$ -1.4M$ 1.91M
9/30/20230$ -1.06M$ 2.3M
6/30/20230$ -9.98M$ 11.52M
3/31/20230$ -7.75M$ 9.33M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NEURAXIS INC's latest trailing twelve months (TTM) D/E stands at 0.
  • Over the past 5 years, NEURAXIS INC's average D/E has been 4.23.
  • The median D/E for NEURAXIS INC during this period was 1.3
  • NEURAXIS INC reached its highest D/E over the past 5 years at 10.72.
  • The lowest D/E recorded by NEURAXIS INC in the same timeframe 0.67

NEURAXIS INC's D/E vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

D/E Benchmarks
CompanyD/E
CAMP : CAMP4 THERAPEUTICS CORP 0.28DYAI : DYADIC INTERNATIONAL INC -LPCN : LIPOCINE INC 0.08TRAW : TRAWS PHARMA INC 0.89LSTA : LISATA THERAPEUTICS INC 0.21STTK : SHATTUCK LABS INC 0.13SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC -LGVN : LONGEVERON INC 0.32BOLT : BOLT BIOTHERAPEUTICS INC 0.94CLSD : CLEARSIDE BIOMEDICAL INC -

Definition of Debt to Equity Ratio

[Calculation] Debt to Equity (D/E) measures the ratio between a company’s [Liabilities] and [Equity]. A high ratio might indicate more risk.
Liabilities / Equity
(=) D/E
D/E for NEURAXIS INC is calculated as follows: Liabilities [ $ 1.59M ] / Equity [ $ -825.66K ]
(=) D/E [ 0 ]

NRXS - Debt to Equity Ratio, Last 5 years

0.67

Minimum

Jun 30, 2025

10.72

Maximum

Mar 31, 2025

4.23

Average

1.3

Median

D/E Benchmark Analysis

The chart above depicts the distribution of D/E for companies in the Total Stock Market. The average D/E of the companies is 1.39 with a standard deviation of 1.31.
The following table provides additional summary stats:
D/E in the Market:
filtered constituents3.3K
min0
max6.05
average1.39
median0.98
std1.31